Table 1.
Demographics of AOSD patients
| Variable | Value |
|---|---|
| Number | 87 |
| Female, n (%) | 69 (79.3) |
| Age at onset (years) | 49.3 ± 19.9 |
| Ferritin (ng/mL) | 11251.2 ± 16997.9 |
| CRP (mg/dL) | 12.4 ± 8.2 |
| ESR (mm(1 h)) | 71.1 ± 30.1 |
| Liver dysfunction, n (%) | 68 (78.1) |
| MAS, n (%) | 23 (26.4) |
| Initial dose of PSL (mg/day) | 41.8 ± 12.2 |
| Steroid pulse, n (%) | 55 (63.2) |
| Immunosuppressant, n (%) | 51 (58.6) |
| Biologics, n (%) | 26 (29.8) |
| Polycyclic systemic type, n (%) | 56 (64.3) |
| Monocyclic systemic type, n (%) | 19 (21.8) |
| Chronic arthritis type, n (%) | 12 (13.7) |
| Relapse, n (%) | 40 (45.9) |
Mean ± standard deviation or number (percentage) is shown
AOSD adult onset Still’s disease, CRP C-reactive protein, ESR erythrocyte sedimentation rate, MAS macrophage activation syndrome, PSL prednisolone